IDH1 and cancer: Cancer cells harboring the IDH mutations, therefore, readily supply 5-C units in the form of 2-OG that can bypass the IDH 1/2 perturbation in the TCA cycle, thereby providing a means whereby d-2-HG can be produced without detriment to the cancer cells [23,24,25,26].